<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Increasing rates of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> worldwide suggest that <z:mp ids='MP_0002055'>diabetes</z:mp> may be caused by environmental toxins </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="113" ids="22977">Cadmium</z:chebi> is a widespread environmental pollutant that accumulates in the pancreas and exerts diabetogenic effects in animals </plain></SENT>
<SENT sid="2" pm="."><plain>To test the hypothesis that exposure to <z:chebi fb="113" ids="22977">cadmium</z:chebi> is associated with impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, we examined the associations between urinary <z:chebi fb="113" ids="22977">cadmium</z:chebi> and the prevalence of impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (<z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e>) and <z:mp ids='MP_0002055'>diabetes</z:mp> in the Third National Health and Nutrition Examination Survey (NHANES III) </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: We analyzed data on 8,722 adults &gt; or =40 years of age from the NHANES III (1988-1994), a cross-sectional health survey of a nationally representative sample of the noninstitutionalized civilian U.S. population </plain></SENT>
<SENT sid="4" pm="."><plain>We studied urinary levels of <z:chebi fb="113" ids="22977">cadmium</z:chebi> (adjusted for urine <z:chebi fb="0" ids="16737">creatinine</z:chebi>) in relation to the prevalence of impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:mp ids='MP_0002055'>diabetes</z:mp>, using the criteria of the American <z:mp ids='MP_0002055'>Diabetes</z:mp> Association </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: After adjustment for age, ethnicity, sex, and BMI, the odds of impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:mp ids='MP_0002055'>diabetes</z:mp> increased dose-dependently with elevations in urinary <z:chebi fb="113" ids="22977">cadmium</z:chebi> from 0-0.99 to 1.00-1.99 and &gt; or =2 micro g/g <z:chebi fb="0" ids="16737">creatinine</z:chebi> (impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, odds ratio [OR] 1.48, 95% CI 1.21-1.82 and OR 2.05, 95% CI 1.42-2.95; <z:mp ids='MP_0002055'>diabetes</z:mp>, OR 1.24, 95% CI 1.06-1.45 and OR 1.45, 95% CI 1.07-1.97) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: In this large cross-sectional study, urinary <z:chebi fb="113" ids="22977">cadmium</z:chebi> levels are significantly and dose-dependently associated with both impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>These findings, which require confirmation in prospective studies, suggest that <z:chebi fb="113" ids="22977">cadmium</z:chebi> may cause <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp> in humans </plain></SENT>
</text></document>